135 related articles for article (PubMed ID: 31246457)
21. Reactivity of Acrylamides Causes Cytotoxicity and Activates Oxidative Stress Response.
Huchthausen J; Escher BI; Grasse N; König M; Beil S; Henneberger L
Chem Res Toxicol; 2023 Aug; 36(8):1374-1385. PubMed ID: 37531411
[TBL] [Abstract][Full Text] [Related]
22. Electrophilic warheads in covalent drug discovery: an overview.
Péczka N; Orgován Z; Ábrányi-Balogh P; Keserű GM
Expert Opin Drug Discov; 2022 Apr; 17(4):413-422. PubMed ID: 35129005
[TBL] [Abstract][Full Text] [Related]
23. Covalent peptides and proteins for therapeutics.
Berdan VY; Klauser PC; Wang L
Bioorg Med Chem; 2021 Jan; 29():115896. PubMed ID: 33285408
[TBL] [Abstract][Full Text] [Related]
24. Covalent Versus Non-covalent Enzyme Inhibition: Which Route Should We Take? A Justification of the Good and Bad from Molecular Modelling Perspective.
Aljoundi A; Bjij I; El Rashedy A; Soliman MES
Protein J; 2020 Apr; 39(2):97-105. PubMed ID: 32072438
[TBL] [Abstract][Full Text] [Related]
25. Quantum Descriptors for Predicting and Understanding the Structure-Activity Relationships of Michael Acceptor Warheads.
Liu R; Vázquez-Montelongo EA; Ma S; Shen J
J Chem Inf Model; 2023 Aug; 63(15):4912-4923. PubMed ID: 37463342
[TBL] [Abstract][Full Text] [Related]
26. NBO, HOMO, LUMO analysis and vibrational spectra (FTIR and FT Raman) of 1-Amino 4-methylpiperazine using ab initio HF and DFT methods.
Mahalakshmi G; Balachandran V
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():321-34. PubMed ID: 25084238
[TBL] [Abstract][Full Text] [Related]
27. Advanced approaches of developing targeted covalent drugs.
Gai C; Harnor SJ; Zhang S; Cano C; Zhuang C; Zhao Q
RSC Med Chem; 2022 Dec; 13(12):1460-1475. PubMed ID: 36561076
[TBL] [Abstract][Full Text] [Related]
28. Protocol for rational design of covalently interacting inhibitors.
Schmidt TC; Welker A; Rieger M; Sahu PK; Sotriffer CA; Schirmeister T; Engels B
Chemphyschem; 2014 Oct; 15(15):3226-35. PubMed ID: 25251382
[TBL] [Abstract][Full Text] [Related]
29. Systematic Study of the Glutathione (GSH) Reactivity of N-Arylacrylamides: 1. Effects of Aryl Substitution.
Cee VJ; Volak LP; Chen Y; Bartberger MD; Tegley C; Arvedson T; McCarter J; Tasker AS; Fotsch C
J Med Chem; 2015 Dec; 58(23):9171-8. PubMed ID: 26580091
[TBL] [Abstract][Full Text] [Related]
30. Electronic absorption, vibrational spectra, nonlinear optical properties, NBO analysis and thermodynamic properties of N-(4-nitro-2-phenoxyphenyl) methanesulfonamide molecule by ab initio HF and density functional methods.
Rajamani T; Muthu S; Karabacak M
Spectrochim Acta A Mol Biomol Spectrosc; 2013 May; 108():186-96. PubMed ID: 23474478
[TBL] [Abstract][Full Text] [Related]
31. bioTCIs: Middle-to-Macro Biomolecular Targeted Covalent Inhibitors Possessing Both Semi-Permanent Drug Action and Stringent Target Specificity as Potential Antibody Replacements.
Yang J; Tabuchi Y; Katsuki R; Taki M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834935
[TBL] [Abstract][Full Text] [Related]
32. Development of Prediction Models for the Reactivity of Organic Compounds with Ozone in Aqueous Solution by Quantum Chemical Calculations: The Role of Delocalized and Localized Molecular Orbitals.
Lee M; Zimmermann-Steffens SG; Arey JS; Fenner K; von Gunten U
Environ Sci Technol; 2015 Aug; 49(16):9925-35. PubMed ID: 26121114
[TBL] [Abstract][Full Text] [Related]
33. CovaDOTS: In Silico Chemistry-Driven Tool to Design Covalent Inhibitors Using a Linking Strategy.
Hoffer L; Saez-Ayala M; Horvath D; Varnek A; Morelli X; Roche P
J Chem Inf Model; 2019 Apr; 59(4):1472-1485. PubMed ID: 30908019
[TBL] [Abstract][Full Text] [Related]
34. Inspired by Nature: The 3-Halo-4,5-dihydroisoxazole Moiety as a Novel Molecular Warhead for the Design of Covalent Inhibitors.
Pinto A; Tamborini L; Cullia G; Conti P; De Micheli C
ChemMedChem; 2016 Jan; 11(1):10-4. PubMed ID: 26607551
[TBL] [Abstract][Full Text] [Related]
35. Quantum chemical characterization of zwitterionic structures: Supramolecular complexes for modifying the wettability of oil-water-limestone system.
Lopez-Chavez E; Garcia-Quiroz A; Gonzalez-Garcia G; Orozco-Duran GE; Zamudio-Rivera LS; Martinez-Magadan JM; Buenrostro-Gonzalez E; Hernandez-Altamirano R
J Mol Graph Model; 2014 Jun; 51():128-36. PubMed ID: 24907932
[TBL] [Abstract][Full Text] [Related]
36. Comparative Evaluation of Covalent Docking Tools.
Scarpino A; Ferenczy GG; Keserű GM
J Chem Inf Model; 2018 Jul; 58(7):1441-1458. PubMed ID: 29890081
[TBL] [Abstract][Full Text] [Related]
37. Nitrofurantoin-melamine monohydrate (cocrystal hydrate): Probing the role of H-bonding on the structure and properties using quantum chemical calculations and vibrational spectroscopy.
Khan E; Shukla A; Jhariya AN; Tandon P; Vangala VR
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Oct; 221():117170. PubMed ID: 31158769
[TBL] [Abstract][Full Text] [Related]
38. Benchmarking in vitro covalent binding burden as a tool to assess potential toxicity caused by nonspecific covalent binding of covalent drugs.
Dahal UP; Obach RS; Gilbert AM
Chem Res Toxicol; 2013 Nov; 26(11):1739-45. PubMed ID: 24164572
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, molecular structure, hydrogen-bonding, NBO and chemical reactivity analysis of a novel 1,9-bis(2-cyano-2-ethoxycarbonylvinyl)-5-(4-hydroxyphenyl)-dipyrromethane: a combined experimental and theoretical (DFT and QTAIM) approach.
Singh RN; Kumar A; Tiwari RK; Rawat P
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Sep; 113():378-85. PubMed ID: 23747377
[TBL] [Abstract][Full Text] [Related]
40. Electronic coupling calculation and pathway analysis of electron transfer reaction using ab initio fragment-based method. I. FMO-LCMO approach.
Nishioka H; Ando K
J Chem Phys; 2011 May; 134(20):204109. PubMed ID: 21639426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
